# James D. Brenton

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-d-brenton/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,546 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 78 |
| i10-index | 215 |
| Last Known Institution | University of Cambridge |
| OpenAlex ID | https://openalex.org/A5051525398 |
| ORCID iD | https://orcid.org/0000-0002-5738-6683 |
| Works | 697 |

## Researcher papers

Showing 12 of 16.

- [The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups](https://scholariq.org/papers/the-genomic-and-transcriptomic-architecture-of-2-000-breast-tumours-reveals/)
- [Liquid biopsies come of age: towards implementation of circulating tumour DNA](https://scholariq.org/papers/liquid-biopsies-come-of-age-towards-implementation-of-circulating-tumour-dna/)
- [Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA](https://scholariq.org/papers/non-invasive-analysis-of-acquired-resistance-to-cancer-therapy-by-sequencing-of/)
- [Rethinking ovarian cancer: recommendations for improving outcomes](https://scholariq.org/papers/rethinking-ovarian-cancer-recommendations-for-improving-outcomes/)
- [Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA](https://scholariq.org/papers/noninvasive-identification-and-monitoring-of-cancer-mutations-by-targeted-deep/)
- [Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial](https://scholariq.org/papers/rucaparib-in-relapsed-platinum-sensitive-high-grade-ovarian-carcinoma-ariel2/)
- [Enhanced detection of circulating tumor DNA by fragment size analysis](https://scholariq.org/papers/enhanced-detection-of-circulating-tumor-dna-by-fragment-size-analysis/)
- [Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?](https://scholariq.org/papers/molecular-classification-and-molecular-forecasting-of-breast-cancer-ready-for/)
- [Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary](https://scholariq.org/papers/mutation-of-i-foxl2-i-in-granulosa-cell-tumors-of-the-ovary/)
- [Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer](https://scholariq.org/papers/identification-of-12-new-susceptibility-loci-for-different-histotypes-of/)
- [<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma](https://scholariq.org/papers/i-brca-i-reversion-mutations-in-circulating-tumor-dna-predict-primary-and/)
- [Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study](https://scholariq.org/papers/hormone-receptor-expression-and-ovarian-cancer-survival-an-ovarian-tumor-tissue/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Molecular Biology Techniques and Applications](https://scholariq.org/topics/molecular-biology-techniques-and-applications/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)

## Researcher university

- [University of Cambridge](https://scholariq.org/institutions/university-of-cambridge/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.